152 related articles for article (PubMed ID: 3244621)
1. Correlation of unbound plasma clearances of fifteen extensively metabolized drugs between humans and rats.
Chiou WL; Hsu FH
Pharm Res; 1988 Oct; 5(10):668-72. PubMed ID: 3244621
[TBL] [Abstract][Full Text] [Related]
2. Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.
Sawada Y; Hanano M; Sugiyama Y; Iga T
J Pharmacokinet Biopharm; 1985 Oct; 13(5):477-92. PubMed ID: 3938813
[TBL] [Abstract][Full Text] [Related]
3. Prediction of the plasma concentration time courses of various drugs in humans based on data from rats.
Sawada Y; Harashima H; Hanano M; Sugiyama Y; Iga T
J Pharmacobiodyn; 1985 Sep; 8(9):757-66. PubMed ID: 4087135
[TBL] [Abstract][Full Text] [Related]
4. Correlation of plasma clearance of 54 extensively metabolized drugs between humans and rats: mean allometric coefficient of 0.66.
Chiou WL; Robbie G; Chung SM; Wu TC; Ma C
Pharm Res; 1998 Sep; 15(9):1474-9. PubMed ID: 9755903
[TBL] [Abstract][Full Text] [Related]
5. Effects of membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver of drugs: A microdialysis study in rats.
Wang S; Chen C; Guan C; Qiu L; Zhang L; Zhang S; Zhou H; Du H; Li C; Wu Y; Chang H; Wang T
Pharmacol Res Perspect; 2021 Oct; 9(5):e00879. PubMed ID: 34628723
[TBL] [Abstract][Full Text] [Related]
6. Drug kinetics and alcohol ingestion.
Sellers EM; Holloway MR
Clin Pharmacokinet; 1978; 3(6):440-52. PubMed ID: 31257
[TBL] [Abstract][Full Text] [Related]
7. Drug concentration in saliva.
Mucklow JC; Bending MR; Kahn GC; Dollery CT
Clin Pharmacol Ther; 1978 Nov; 24(5):563-70. PubMed ID: 29738
[TBL] [Abstract][Full Text] [Related]
8. Prediction of the volumes of distribution of basic drugs in humans based on data from animals.
Sawada Y; Hanano M; Sugiyama Y; Harashima H; Iga T
J Pharmacokinet Biopharm; 1984 Dec; 12(6):587-96. PubMed ID: 6533294
[TBL] [Abstract][Full Text] [Related]
9. Developmental changes in the liver weight- and body weight-normalized clearance of theophylline, phenytoin and cyclosporine in children.
Kanamori M; Takahashi H; Echizen H
Int J Clin Pharmacol Ther; 2002 Nov; 40(11):485-92. PubMed ID: 12698985
[TBL] [Abstract][Full Text] [Related]
10. An analysis of the effect of hypoalbuminemia on the amount of free drug in plasma for drugs bound at two sets of sites.
Wosilait WD
Res Commun Chem Pathol Pharmacol; 1974 Dec; 9(4):681-8. PubMed ID: 4456500
[No Abstract] [Full Text] [Related]
11. Clinical relevance of the effect of hepatic disease on drug disposition.
Bond WS
Am J Hosp Pharm; 1978 Apr; 35(4):406-14. PubMed ID: 645712
[TBL] [Abstract][Full Text] [Related]
12. Quantitative structure--clearance relationships of acidic drugs.
Zhivkova Z; Doytchinova I
Mol Pharm; 2013 Oct; 10(10):3758-68. PubMed ID: 23898951
[TBL] [Abstract][Full Text] [Related]
13. Influence of acute renal failure on the protein binding of drugs in animals and in man.
Belpaire FM; Bogaert MG; Mussche MM
Eur J Clin Pharmacol; 1977; 11(1):27-32. PubMed ID: 832654
[TBL] [Abstract][Full Text] [Related]
14. Rapid method for screening toxic drugs in serum with liquid chromatography.
Kabra PM; Stafford BE; Marton LJ
J Anal Toxicol; 1981; 5(4):177-82. PubMed ID: 7278154
[TBL] [Abstract][Full Text] [Related]
15. Use of saliva in therapeutic drug monitoring.
Horning MG; Brown L; Nowlin J; Lertratanangkoon K; Kellaway P; Zion TE
Clin Chem; 1977 Feb; 23(2 PT. 1):157-64. PubMed ID: 318941
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a liver microfluidic biochip to predict in vivo clearances of seven drugs in rats.
Baudoin R; Legendre A; Jacques S; Cotton J; Bois F; Leclerc E
J Pharm Sci; 2014 Feb; 103(2):706-18. PubMed ID: 24338834
[TBL] [Abstract][Full Text] [Related]
17. The use of single sample clearance estimates to probe hepatic drug metabolism in rats. I.
Bachmann KA; Yang C; Jahn D; Schwartz J
Xenobiotica; 1988 Feb; 18(2):151-9. PubMed ID: 3131969
[TBL] [Abstract][Full Text] [Related]
18. Drug protein binding and the nephrotic syndrome.
Gugler R; Azarnoff DL
Clin Pharmacokinet; 1976; 1(1):25-35. PubMed ID: 797490
[TBL] [Abstract][Full Text] [Related]
19. IMPLICATIONS ON ENZYME INDUCTION FOR DRUG THERAPY.
BURNS JJ
Am J Med; 1964 Sep; 37():327-31. PubMed ID: 14218162
[No Abstract] [Full Text] [Related]
20. A micromethod for the isolation of drugs from blood using amberlite XAD-2.
Schlicht HJ; Gelbke HP
Z Rechtsmed; 1978 Mar; 81(1):25-30. PubMed ID: 654595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
